Chemomab Therapeutics Ltd. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Chemomab Therapeutics Ltd. annual/quarterly Depreciation history and growth rate from 2018 to 2023.
  • Chemomab Therapeutics Ltd. Depreciation for the quarter ending March 31, 2023 was $16K, a 23.1% increase year-over-year.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2023 was $67K, a 15.5% increase from 2022.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2022 was $58K, a 70.6% increase from 2021.
  • Chemomab Therapeutics Ltd. annual Depreciation for 2021 was $34K, a 41.7% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $67K +$9K +15.5% Jan 1, 2023 Dec 31, 2023 20-F 2024-03-28
2022 $58K +$24K +70.6% Jan 1, 2022 Dec 31, 2022 20-F 2024-03-28
2021 $34K +$10K +41.7% Jan 1, 2021 Dec 31, 2021 20-F 2024-03-28
2020 $24K -$257K -91.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $281K +$215K +326% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $66K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.